NCT02021019View on ClinicalTrials.gov

Renal Denervation to Improve Outcomes in Patients With End-stage Renal Disease

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
End-stage Renal DiseaseHypertension
Interventions
PROCEDURE

Renal Denervation

Renal Denervation

Trial Locations (1)

3004

Baker IDI Heart and Diabetes Institute, Melbourne

All Listed Sponsors
lead

Baker Heart and Diabetes Institute

OTHER

NCT02021019 - Renal Denervation to Improve Outcomes in Patients With End-stage Renal Disease | Biotech Hunter | Biotech Hunter